AI assistant
Sending…
IMMUCELL CORP /DE/ — Director's Dealing 2011
Mar 15, 2011
34519_dirs_2011-03-15_81e9097a-7f33-428f-8743-7bc2f59bdfef.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2011-03-11
Reporting Person: ROTHSCHILD JONATHAN E (Director, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-03-11 | Common Stock, par value $0.10 per share | P | 820 | $3.12 | Acquired | 463170 | Direct |
| 2011-03-15 | Common Stock, par value $0.10 per share | P | 600 | $3.25 | Acquired | 463770 | Direct |
Footnotes
F1: This figure includes 214,155 shares of common stock held by Arterio, Inc., a company solely owned by Mr. Rothschild.
More from IMMUCELL CORP /DE/
Regulatory Filings
2026
May 14
Annual Report
2026
May 13
Regulatory Filings
2026
May 8
Proxy Solicitation & Information Statement
2026
Apr 24
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 14
Regulatory Filings
2026
Apr 8
Annual Report
2026
Mar 30
Director's Dealing
2026
Mar 25
Director's Dealing
2026
Mar 23